logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Ken Masuda

the school of tropical medicine and global health
H指数:22
被引数:2,624

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA study

30天内出现皮肤疾病是接受尼妥珠单抗联合吉西他滨和顺铂治疗的肺鳞状细胞癌患者的有利预后因素：NINJA研究的亚组分析

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2025-03-150
OA
Fumihiko Kinoshita; Shigeru Tanzawa; Toshihiro Misumi; Hiroshige Yoshioka; Eisaku Miyauchi; Kiichiro Ninomiya; Yasunori Murata; Masafumi Takeshita; Masafumi Yamaguchi; Shunichi Sugawara; Yosuke Kawashima; Kazuki Hashimoto; Masahide Mori; Akihiko Miyanaga; Anna Hayashi; Hisashi Tanaka; Ryoichi Honda; Masafumi Nojiri; Yuki Sato; Ken Yamamoto; Ken Masuda; Toshiyuki Kozuki; Takahisa Kawamura; Takuji Suzuki; Teppei Yamaguchi; Kazuhiro Asada; Satoshi Tetsumoto; Hiroshi Tanaka; Satoshi Watanabe; Yukihiro Umeda; Kakuhiro Yamaguchi; Shoichi Kuyama; Kosuke Tsuruno; Yuki Misumi; Hiroshi Kuraishi; Ken Yoshihara; Akira Nakao; Akihito Kubo; Toshihiko Yokoyama; Kana Watanabe; Nobuhiko Seki
Final Analysis Data and Exploratory Biomarker Analysis of a Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib Monotherapy for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: The WJOG9717L Study
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2024-11-011
OA
Kenmotsu, Hirotsugu; Sakai, Kazuko; Mori, Keita; Kato, Terufumi; Sugawara, Shunichi; Kirita, Keisuke; Yoneshima, Yasuto; Azuma, Koichi; Nishino, Kazumi; Teraoka, Shunsuke; Koyama, Ryo; Masuda, Ken; Hayashi, Hidetoshi; Toyozawa, Ryo; Miura, Satoru; Sato, Yuki; Nakagawa, Kazuhiko; Yamamoto, Nobuyuki; Nishio, Kazuto; Takahashi, Toshiaki
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2023-12-014
OA
Murata, Yasunori; Tanzawa, Shigeru; Misumi, Toshihiro; Yoshioka, Hiroshige; Miyauchi, Eisaku; Ninomiya, Kiichiro; Takeshita, Masafumi; Ito, Kensaku; Okamoto, Tatsuro; Sugawara, Shunichi; Kawashima, Yosuke; Hashimoto, Kazuki; Mori, Masahide; Miyanaga, Akihiko; Hayashi, Anna; Tanaka, Hisashi; Honda, Ryoichi; Nojiri, Masafumi; Sato, Yuki; Hata, Akito; Masuda, Ken; Kozuki, Toshiyuki; Kawamura, Takahisa; Suzuki, Takuji; Yamaguchi, Teppei; Asada, Kazuhiro; Tetsumoto, Satoshi; Tanaka, Hiroshi; Watanabe, Satoshi; Umeda, Yukihiro; Yamaguchi, Kakuhiro; Kuyama, Shoichi; Tsuruno, Kosuke; Misumi, Yuki; Kuraishi, Hiroshi; Yoshihara, Ken; Nakao, Akira; Kubo, Akihito; Yokoyama, Toshihiko; Watanabe, Kana; Seki, Nobuhiko
Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer (vol 129, 2034, 2023)
BRITISH JOURNAL OF CANCER
IF6.8
2023-11-031
OA
Shirasawa, Masayuki; Yoshida, Tatsuya; Shiraishi, Kouya; Goto, Naoko; Yagishita, Shigehiro; Imabayashi, Tatsuya; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yotsukura, Masaya; Yoshida, Yukihiro; Nakagawa, Kazuo; Naoki, Katsuhiko; Tsuchida, Takaaki; Hamamoto, Ryuji; Yamamoto, Noboru; Motoi, Noriko; Kohno, Takashi; Watanabe, Shun-ichi; Ohe, Yuichiro
Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer
BRITISH JOURNAL OF CANCER
IF6.8
2023-09-208
OA
Shirasawa, Masayuki; Yoshida, Tatsuya; Shiraishi, Kouya; Goto, Naoko; Yagishita, Shigehiro; Imabayashi, Tatsuya; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yotsukura, Masaya; Yoshida, Yukihiro; Nakagawa, Kazuo; Naoki, Katsuhiko; Tsuchida, Takaaki; Hamamoto, Ryuji; Yamamoto, Noboru; Motoi, Noriko; Kohno, Takashi; Watanabe, Shun-ichi; Ohe, Yuichiro
Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC Patients

同时高PD-L1表达和CD8免疫细胞浸润预测晚期EGFR突变型NSCLC患者的PD-1阻断效果

CLINICAL LUNG CANCER
IF3.3
2022-09-0112
PRE
Shimoda, Yukiko; Shibaki, Ryota; Yoshida, Tatsuya; Murakami, Shuji; Shirasawa, Masayuki; Torasawa, Masahiro; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yamamoto, Noboru; Ohe, Yuichiro; Motoi, Noriko

研究方向

暂未获取到该数据
Y
Yasushi Goto
H 指数:41论文数:483被引数:8,643
H
Hidehito Horinouchi
H 指数:38论文数:430被引数:5,768
Y
Yuki Shinno
H 指数:19论文数:132被引数:1,934
Y
Yusuke Okuma
H 指数:30论文数:397被引数:4,123
Y
Yuichiro Ohe
H 指数:76论文数:958被引数:4.1万
N
Noboru Yamamoto
H 指数:66论文数:1,329被引数:1.8万
T
Tatsuya Yoshida
H 指数:32论文数:374被引数:7,717
Y
Yuji Matsumoto
H 指数:27论文数:231被引数:2,559
Y
Yataro Daigo
H 指数:69论文数:457被引数:1.5万
Y
Yoshida, Tatsuya
H 指数:0论文数:40被引数:4